Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (201-210 of 361) with videos related to

Pageof 37
Sort By:
Blood|March 17, 2012
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabineThomas Pabst, Edo Vellenga, Wim van Putten, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Haematologica|December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen P Robinson, Anna Sureda, Carmen Canals, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patientsAgustin Resendiz-Sharpe, Toine Mercier, Pieter P A Lestrade, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
British Journal of Haematology|August 26, 2015
Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow TransplantationSimone Cesaro, Regis Peffault de Latour, Gloria Tridello, et al.
Cancer|December 17, 2013
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMoshe Yeshurun, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|January 7, 2023
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Mohamed Houhou, et al.
Pageof 37

Showing results (201-210 of 361) with videos related to

Sort By:
Pageof 37
Blood|March 17, 2012
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabineThomas Pabst, Edo Vellenga, Wim van Putten, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
The Lancet. Haematology|December 22, 2015
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysisJurjen Versluis, Carin L E Hazenberg, Jakob R Passweg, et al.
Haematologica|December 11, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen P Robinson, Anna Sureda, Carmen Canals, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2019
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patientsAgustin Resendiz-Sharpe, Toine Mercier, Pieter P A Lestrade, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
British Journal of Haematology|August 26, 2015
Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow TransplantationSimone Cesaro, Regis Peffault de Latour, Gloria Tridello, et al.
Cancer|December 17, 2013
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMoshe Yeshurun, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|January 7, 2023
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Mohamed Houhou, et al.
Pageof 37